Background: Spinal anesthesia in the sitting position with low-dose local anesthetics usually provides satisfactory anesthesia for diabetic foot surgery because most operations do not require tourniquet application. This study was designed to investigate the influence of different sitting periods after subarachnoid injection of low dose bupivacaine on the spread of analgesia.
INTRODUCTION
A diabetic foot ulcer is a serious complication of long-term diabetes. Surgery for the diabetic foot is a relatively minor operation with negligible blood loss, but providing anesthesia for these patients is a frequent challenge because of serious comorbidities. Cardiovascular autonomic neuropathy is associated with increased morbidity and mortality [1] , and hemodynamic instability is common in patients with autonomic dysfunction during anesthesia induction and maintenance [2, 3] . It is important to maintain anesthesia as stable as possible including adequate analgesia.
Although there is no clear evidence that one type of anesthetic is superior for patients with diabetes, the stress response to surgery may be reduced with combinations of local or regional anesthesia and the administration of opioids [4] .
Regional anesthesia is a reasonable choice for lower extremity operations in diabetic patients [5] . When spinal anesthesia is planned, high sensory block levels are not required, especially when a tourniquet is not used. Limiting the block to lower dermatomal levels and avoiding the occurrence of hypotension is important because fluid loading and vasopressor administration may not be ideal methods to prevent or treat hypotension since end-stage renal disease and coronary artery occlusive disease are common in these patients. A peak level of sensory block of only L4 or even L5 provides sufficient anesthesia, and spinal anesthesia with a low dose of local anesthetics with the patient in the sitting position is one method to minimize analgesic level and the occurrence of hypotension. It has been suggested that when compared with the general population, patients with preexisting sensorimotor neuropathy or diabetic polyneuropathy may be at increased risk of further neurologic sequelae after neuraxial anesthesia or analgesia [6, 7] .
Diabetic nerve fibers may be more susceptible to the toxic effects of local anesthetics [7] . Minimizing the concentration of local anesthetics can be safe for patients undergoing diabetic foot surgery.
This study was designed to investigate the influence of different sitting periods after subarachnoid injection of a small dose (3.75 mg) of hyperbaric 0.25% bupivacaine on the spread of analgesia.
MATERIALS AND METHODS
After obtaining approval from the Hospital Ethics Committee and written informed consent from the subjects, sixty adult patients undergoing diabetic foot surgery without tourniquet were enrolled in this study. All patients were admitted prior to the surgical procedure for daily dressing and control of infection of diabetic foot. Patients were checked for sensory dysfunction in the dermatomes of the lower extremities to exclude pre-existing sensory loss from diabetic neuropathy. Patients were excluded from the study if they had coagulopathy, infection at the site of injection, or refusal to spinal anesthesia as well as pre-existing sensory loss. Subjects were randomly assigned to one of three study groups that differed with respect to the duration that patients remained in the sitting position after injection of an anesthetic agent. Group assignment was randomized using computer-generated randomization.
Premedication was not given to patients. When patients arrived at the operating theatre, routine monitoring, including electrocardiogram, pulse-oximetry and non-invasive automated blood pressure were established. Heart rate (HR) and mean ar- For the purpose of statistical analyses, each dermatomal level was scored in sequence starting at S5 = 1, such that S1 = 5, L1 = 10, T8 = 15, and T3 = 20. Sample size was calculated based on the pilot study, since there was no previous study about the influence of different sitting periods after sub- Values are mean ± SD or numbers. Patients in groups D2, D5 and D10 remained sitting for 2, 5 or 10 min after completion of the subarachnoid injection. Significantly different compared to Group D10 (P = 0.002).
arachnoid injection of low dose 3.75 mg of 0.25% bupivacaine on the spread of analgesia. Based on the results of our pilot study, more than 14 patients in each group were required in order to detect a difference of one dermatome analgesia levels to pinprick with a variability of 0.9 between with α error of 0.05 and β error of 0.2. We decided to evaluate 20 patients in each group to compensate for possible protocol violations during the study period.
Statistical analyses were performed using software packages Table 1 . There were no differences among the groups. Hypertension, coronary artery occlusive disease, and end-stage renal disease were found in 76.7%, 38.3%, and 41.7% of all patients, respectively.
The characteristics of sensory block are presented in Table 2 .
The individual times to MSBL revealed that sensory block level was fixed within 5 min in 28 out of 60 patients and the Significantly different compared to Group D2 and D10 (P ＜ 0.008).
longest time for fixation was 20 min in each group. The highest sensory block levels were T12, T11, and L2 in Group D2, 5, and 10, respectively. MSBL of Group D2 was 1 dermatome higher than that of Group D10 (P = 0.002) ( Table 2) (Fig. 1) .
MSBL of Group D10 showed the limited distribution of the local anesthetics (Table 2) (Fig. 1 ). There were no differences in the time to MSBL or increased levels of sensory block after supine positioning among the groups or two segment regression time.
Analgesia was adequate during the whole period of surgery except for one patient in Group D2. Although the initial sensory block was adequate, this patient required additional infusion of intravenous remifentanil due to prolonged operation time (85 min after the induction of anesthesia).
Changes in mean arterial pressure and heart rate were comparable among the groups (Fig. 2, 3 
DISCUSSION
In this study, spinal anesthesia using 3.75 mg of hyperbaric 0.25% bupivacaine in the sitting position ensured adequate anesthesia and maintained stable hemodynamics regardless of the duration of sitting. Although there was only one segment difference in MSBL between Group D2 and D10 statistically (P = 0.002), we found that the 10 min sitting period was required to confine the sensory blockade on the lower level. The highest MSBL was confined to L2 in Group D10, whereas the highest MSBL in Group D2 and D5 were T12 and T11, respectively, even with small dose of bupivacaine. Significantly different compared to Group D2 and D10 (P = 0.002). There are three reasons to use 0.25% bupivacaine solution instead of 0.5%. First, when using the undiluted 0.5% bupivacaine solution in the sitting position, there is a high risk of localized anesthesia within the S-dermatome region. Secondly, it is highly probable that patients with DM foot disease also have nerve fiber neuropathies. It has been previously reported that DM patients are at a high risk of developing toxicity due to local anesthetics when used in high concentrations [6, 7] , and concentrations as low as 0.25% can induce sufficient sensory and motor block in these patients. Finally, because 0.25% bupivacaine is weakly hyperbaric and thus settles at a slow rate at the injection site, we can anticipate effective analgesia at the desired dermatomes (below L3) than with high concentration local anesthetics such as 0.5% bupivacaine.
Among many factors that affect the intrathecal spread of local anesthetics, the major factors are the baricity of the injected solution and the posture of the patient [8] . Although it is generally believed that injection of hyperbaric local anesthetic solution in the sitting position would limit MSBL to lower levels, earlier studies on the time that the patient is kept in the sitting position after the subarachnoid injection of high doses (15−20 mg) of hyperbaric bupivacaine have demonstrated that the time in the sitting position has little or no influence on the maximum cephalad spread of sensory analgesia [9] [10] [11] [12] . The results were mainly determined by the final position of the patients. When a larger volume (4 ml) of 0.5% bupivacaine was injected, even a sitting period of 60 min was not enough for the fixation of analgesic levels [12] . We used a small-dose (3.75 mg) of 0.25% hyperbaric bupivacaine unlike previous investigations [9] [10] [11] [12] .
We did not measure sensory block level at 2 min when patients were moved into the supine position in Group D2, but there is a possibility that there was 1 segment upward progression between 2−5 min in this group compared to others because sensory block level at 5 min in Group D2 was 1 segment higher than that of Group D5 or D10 (Fig. 4) . After 5 min, increased sensory block level in Group D2 was similar to increased sensory level after supine positioning in Groups D5 and D10. This would mean that when even a small dose of local anesthetic is injected into the subarachnoid space with the patient in the sitting position, a 2-min period of sitting is not sufficient enough to limit analgesic level. Although there was no statistical difference between Group D5 and D10 in regard to MSBL, a 10-min sitting period after subarachnoid injection is preferable for achieving a more consistent analgesic level because MSBL was demonstrated to have a lower inter-individual variability in Group D10 (Fig. 5) . In addition, MSBL was fixed during the period when the patient was sitting in 15 patients in Group D10 (75.0%) compared to 8 pa- Diluting 0.5% intrathecal bupivacaine in 8% dextrose solution with the same volume of saline was reported to have a faster recovery time [15] , but this is a controversial issue because it is generally accepted that dosage rather than volume or concentration of the solution is the main factor that determines the duration of the block [17] . This was not a primary investigation point of this study. We used 3.75 mg of 0.25% hyperbaric bupivacaine and decreasing the bupivacaine dose could be considered but it might result in inadequate analgesia for the surgery because MSBL of 2 patients were already as low as L5 with 3.75 mg. Although all patients in this study showed stable hemodynamics during the period of sitting position except one patient, ten minutes sitting for diabetic patients after subarachnoid injection can cause fainting. Careful monitoring is mandatory for these patients during the sitting period.
There are some limitations to this study. First, the measurement of analgesia level at 2 min in Group D2 was not performed. This made it impossible to investigate actual increased sensory block level after subjects in this group changed to the supine position. Second, we used a 22-gauge Quincke spinal needle because it is still the most commonly used in our department. Using the different types and gauges of spinal needle could result in different distribution of local anesthetics [16, 17] . Among the different types of spinal needles, the Quincke needle can always produce an undeviated stream of anesthetics and do not form tracks at any flow rate [18] .
In conclusion, this study demonstrated that spinal anesthesia using a minimal dose of 0.25% hyperbaric bupivacaine with the patient in a sitting position provided adequate anesthesia for diabetic foot surgery without profound hypotension regardless of the time spent in the sitting position (2, 5, or 10 min) after subarachnoid injection. However, even with this small dose, keeping the patient in the sitting position for 2 or 5 min after subarachnoid injection was not adequate to confine the sensory blockade on the lower dermatome.
